Skip to content

Translation and Validation of the Intensive Care Unit Mobility Scale (IMS)

Übersetzung Und Validierung Einer Deutschen Version Der Intensive Care Unit Mobility Scale (IMS) Translation and Validation of the Intensive Care Unit Mobility Scale (IMS)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05591950
Acronym
TAVIMS
Enrollment
100
Registered
2022-10-24
Start date
2023-01-24
Completion date
2025-02-20
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Early Mobilization, Mechanical Ventilation Complication, Muscle Weakness

Keywords

ICU-mobility-scale

Brief summary

Intensive care unit acquired weakness (ICUAW) is a common issue in critically ill patients. Early mobilization can reduce the occurrence of ICUAW. This requires a standardized procedure based on validated scales. One such scale is Carol Hodgson's ICU Mobility Scale (IMS). The subject of the study is the translation of the IMS into German and the validation of its reliability and predictive power with regard to various clinical outcomes. Furthermore we want to investigate the communication about the mobilisation status of ICU-patients between the different medical disciplines that are involved in patient care.

Interventions

None listed

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Critically ill adults (age: ≥ 18 years) * Expected length of stay in ICU \> 24h * Ventilation support

Exclusion criteria

* Patients transferred from other ICUs * Patients with pre-existing functional limitations * Patients with functional limitations due to the admission diagnosis (e.g. stroke. with hemiparesis)

Design outcomes

Primary

MeasureTime frameDescription
Predictive validity of the IMSapproximate 28 days (till ICU discharge)Predictive validity of the IMS-score performed in the first 24 hours after admission to the ICU for the length of stay in the ICU

Secondary

MeasureTime frameDescription
90-day mortalityat 90 daysMortality at 90 days
90-day functionat 90 daysPhysical function of the patient at 90 days
MRC Scoreapproximate 28 days (till ICU discharge)Muscle strength at ICU discharge measured using the Medical Research Council score
ICU mortalityapproximate 28 days (till ICU discharge)Mortality during ICU stay
Duration of mechanical ventilationapproximate 28 days (till ICU discharge)Duration of invasive mechanical ventilator dependency
Muscle strengthapproximate 28 days (till ICU discharge)Muscle strength at ICU discharge measured using hand grip strength
IMS during the ICU stayapproximate 28 days (till ICU discharge)achieved mobilization level during the ICU stay using the ICU Mobility Scale (IMS)
ICU-LOSapproximate 28 days (till ICU discharge)Length of stay in the ICU
Hospital LOSapproximate 28 days (till discharge)Length of stay in the hospital
in-hospital mortalityapproximate 28 days (till discharge)Mortality during the Hospital stay
Discharge locationapproximate at 28 days (at hospital discharge)If the patient was discharged home or to another facility at hospital discharge

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026